These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15577056)

  • 1. [Regulation of calcification by bisphosphonates].
    Ono K; Wada S
    Clin Calcium; 2004 Jun; 14(6):60-3. PubMed ID: 15577056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of the bisphosphonates.
    Fleisch H
    Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonates for vascular calcification].
    Tanaka Y; Okada Y
    Clin Calcium; 2007 Mar; 17(3):386-90. PubMed ID: 17339743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases.
    Schuetz P; Mueller B; Christ-Crain M; Dick W; Haas H
    Spinal Cord; 2005 Oct; 43(10):604-10. PubMed ID: 15867938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report).
    Stover SL; Hahn HR; Miller JM
    Paraplegia; 1976 Aug; 14(2):146-56. PubMed ID: 823516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates and atherosclerosis.
    Ylitalo R
    Gen Pharmacol; 2000 Dec; 35(6):287-96. PubMed ID: 11922958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
    Neven EG; De Broe ME; D'Haese PC
    Kidney Int; 2009 Mar; 75(6):580-2. PubMed ID: 19247382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
    Lomashvili KA; Monier-Faugere MC; Wang X; Malluche HH; O'Neill WC
    Kidney Int; 2009 Mar; 75(6):617-25. PubMed ID: 19129793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
    Nancollas GH; Tang R; Phipps RJ; Henneman Z; Gulde S; Wu W; Mangood A; Russell RG; Ebetino FH
    Bone; 2006 May; 38(5):617-27. PubMed ID: 16046206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP.
    Finerman GA; Stover SL
    Metab Bone Dis Relat Res; 1981; 3(4-5):337-42. PubMed ID: 6820114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positioning of bisphosphonates for vascular calcification].
    Okada Y; Mori H; Tanaka Y; Hashimoto O
    Clin Calcium; 2010 Nov; 20(11):1711-7. PubMed ID: 21037392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterotopic ossification in patients after total hip replacement.
    Stołtny T; Koczy B; Wawrzynek W; Miszczyk L
    Ortop Traumatol Rehabil; 2007; 9(3):264-72. PubMed ID: 17721424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rofecoxib inhibits heterotopic ossification after total hip arthroplasty.
    van der Heide HJ; Koorevaar RC; Lemmens JA; van Kampen A; Schreurs BW
    Arch Orthop Trauma Surg; 2007 Sep; 127(7):557-61. PubMed ID: 17106714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin in prevention of heterotopic ossification.
    Buschbacher R; McKinley W; Buschbacher L; Devaney CW; Coplin B
    Am J Phys Med Rehabil; 1992 Apr; 71(2):86-91. PubMed ID: 1558739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
    Masho Y; Shigematsu T
    Clin Calcium; 2007 Mar; 17(3):354-9. PubMed ID: 17339739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?
    Persy V; De Broe M; Ketteler M
    Kidney Int; 2006 Nov; 70(9):1537-8. PubMed ID: 17051257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin of osteoprogenitor cells responsible for heterotopic ossification following hip surgery: an animal model in the rabbit.
    Rumi MN; Deol GS; Singapuri KP; Pellegrini VD
    J Orthop Res; 2005 Jan; 23(1):34-40. PubMed ID: 15607872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates may inhibit development of atherosclerosis formation through its bactericidal effect on nanobacteria.
    Silay YS; Altundag K; Altundag O; Atik MA; Ozen M
    Med Hypotheses; 2005; 64(6):1239-40. PubMed ID: 15823727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.